ICS-formoterol reliever versus ICS and short-acting ß2-agonist reliever in asthma: a systematic review and meta-analysis

Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley

Source: ERJ Open Res, 7 (1) 00701-2020; 10.1183/23120541.00701-2020
Journal Issue: January

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Lee Hatter, Pepa Bruce, Irene Braithwaite, Mark Holliday, James Fingleton, Mark Weatherall, Richard Beasley. ICS-formoterol reliever versus ICS and short-acting ß2-agonist reliever in asthma: a systematic review and meta-analysis. ERJ Open Res, 7 (1) 00701-2020; 10.1183/23120541.00701-2020

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: